ACC/AHA guidelines on dabigatran in Afib

By  |  February 15, 2011 | 

The ACCF/AHA/HRS just published guidelines on the use of dabigatran in Afib. This was a focused update for the 2006 full guidelines on the management of Afib. They recommend to continue warfarin in patients who are currently on it and well maintained (therapeutic INR). For all other patients, dabigatran can be considered, after consideration of: twice daily dosing, lack of antidote in case of bleeding, creatinine clearance (not to be used if CrCl<15, and reduced dose for crcl 15-30), and cost (ACC update)

About the Author:

Danielle Scheurer
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Categories

Related Posts

By  | July 5, 2016 |  0
What comes to mind when you think of getting CME? I bet most of you would say sitting in an auditorium, whether that be during your local grand rounds or at our professional society meeting, like Hospital Medicine 16 in sunny San Diego this past March. Hanging out in the Twitterverse? Probably not so much… […]
By  | December 3, 2013 |  1
As a nurse practitioner in hospital medicine I have multiple opportunities to interact with all sorts of physician hospitalist colleagues, hospital medicine group leaders, quality officers etc.  Often their interactions with me take on a certain wary curiosity, like I am some exotic monkey or another creature that is unfamiliar to them.  If I am […]
By  | September 24, 2013 |  2
By reading the headlines recently, practitioners would not know if they saved or tanked the healthcare system.  One day disaster looms, the next we have moderated growth and business can continue as usual (and by business, I mean doing the correct things correctly). A new study, along with some recent data, helps shed some light […]

Leave A Comment